NASDAQ: BCTX
Briacell Therapeutics Revenue

Briacell Therapeutics revenue was $0.00 for the trailing 12 months ending Jan 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Jan 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Jul 31, 2024, BCTX annual revenue was $0.0, with N/A growth year-over-year.

BCTX revenue history

Current Revenue
$0.0
Current Earnings
-$11.8M
Current Profit Margin
0%

Be the first to know when BCTX announces revenue.

BCTX Revenue History By Year

BCTX Yearly RevenueBCTX RevenueBCTX ChangeBCTX Revenue Growth
2024-07-31$0.00N/AN/A
2023-07-31$0.00N/AN/A
2022-07-31$0.00N/AN/A
2021-07-31$0.00N/AN/A
2020-07-31$0.00N/AN/A
2019-07-31$0.00N/AN/A
2018-07-31$0.00N/AN/A

1 of 1

Briacell Therapeutics Revenue FAQ

What was BCTX's revenue last quarter?

On Invalid Date, Briacell Therapeutics (NASDAQ: BCTX) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Briacell Therapeutics's revenue was $0.00.

What was Briacell Therapeutics's revenue in 2024?

Briacell Therapeutics's annual revenue for the twelve months ending Jul 31, 2024 was $0.00, a N/A decrease year over year.

How much does Briacell Therapeutics make in a day?

Based on Briacell Therapeutics annual revenue for the past five years, BCTX makes an average of $0.00 per day.

What was Briacell Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Briacell Therapeutics's revenue has grown null year over year. Briacell Therapeutics's revenue in the past year totaled $0.00.

How much does Briacell Therapeutics make in a year?

Briacell Therapeutics's revenue by year for the past five years is:
  • Briacell Therapeutics's revenue for the twelve months ending Jul 31, 2024 was $0.00, a N/A decrease year over year.
  • Briacell Therapeutics's annual revenue for Jul 31, 2023 was $0.00, a N/A decrease from 2022.
  • Briacell Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Briacell Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Briacell Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.